Uquifa is a CDMO for small molecule novel chemical entities (NCEs) headquartered in Barcelona, Spain, with three GMP manufacturing facilities and three research centers across Europe and North America. The company has over 80 years of experience in small molecule pharmaceutical drug development and provides R&D and GMP manufacturing of APIs and advanced intermediates. Uquifa also provides laboratory services, development of novel synthetic routes, scale-up from pilot plant to commercial-scale production, and tech transfer of commercial-scale processes.